BioSpace News Archive

Press Releases

IDEAYA Announces Positive Interim Phase 1 Expansion Data of IDE397 in MTAP-Deletion Urothelial and Lung Cancer as Late-Breaker Oral Presentation at EORTC-NCI-AACR 2024

October 25, 2024
·
12 min read
Press Releases

Avantor® Reports Third Quarter 2024 Results

October 25, 2024
·
21 min read
News

MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia

October 25, 2024
·
3 min read
News

Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024

October 25, 2024
·
2 min read
News

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

October 25, 2024
·
4 min read
News

Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College of Allergy Asthma and Immunology (ACAAI) 2024 Annual Meeting

October 25, 2024
·
9 min read
Press Releases

Jupiter Endovascular Announces First U.S. Patient Treated With Vertex Pulmonary Embolectomy System Using Endoportal Control

October 25, 2024
·
3 min read
Press Releases

Dermavant Presents ADORING 3 LTE Final Data on Complete Skin Clearance and Treatment-Free Interval for VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as Two Years Old with Atopic Dermatitis at 2024 Fall Clinical Dermatology Conference

October 25, 2024
·
8 min read
News

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

October 25, 2024
·
7 min read
Drug Development

Maze Therapeutics Reports Positive First-in-Human Data From Phase 1 Healthy Volunteer Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease (AKD)

October 25, 2024
·
3 min read